| ACTA2 | Alpha-smooth muscle actin |
| Alix | ALG-2 interacting protein |
| AMD | Age-related macular degeneration |
| BMDM | Bone marrow-derived macrophages |
| CD | Cluster of differentiation |
| CNS | Central nervous system |
| CuAAC | Copper-catalyzed azide-alkyne cycloaddition |
| CXCL10 | C-X-C motif chemokine ligand 10 |
| DC | Dendritic cell |
| DC-STAMP | Dendritic cell-specific transmembrane protein |
| ECM | Extracellular matrix |
| EV | Extracellular vesicle |
| FDA | U.S. Food and Drug Administration |
| FGF | Fibroblast growth factor |
| FLS | Fibroblast-like synoviocyte |
| GAP-43 | Growth-associated protein-43 |
| GFAP | Glial fibrillary acidic protein |
| HHP | High-hydrostatic pressure |
| Hsp70 | Heat shock protein 70 |
| HUVEC | Human umbilical vein endothelial cells |
| IFN-α | Interferon-alpha |
| IGF-1 | Insulin-like growth factor-1 |
| IL-33 | Interleukin-33 |
| LPS | Lipopolysaccharide |
| MBV | Matrix-bound nanovesicle |
| MCP-3 | Monocyte chemotactic protein 3 |
| MECM | ECM-educated macrophage phenotype |
| miRNA | microRNA |
| MISEV | Minimal Information for Studies of Extracellular Vesicles |
| MSC | Mesenchymal stem cell |
| NFATc1 | Nuclear factor of activated T-cells, cytoplasmic 1 |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NTA | Nanoparticle tracking analysis |
| PEG | Poly(ethylene glycol) |
| RANKL | Receptor activator of nuclear factor kappa-B ligand |
| RGC | Retinal ganglion cell |
| RPE | Retinal pigment epithelium |
| SEC | Size-exclusion chromatography |
| siRNA | Small interfering RNA |
| SIS | Small intestinal submucosa |
| SPAAC | Strain-promoted alkyne-azide cycloaddition |
| ST2 | Suppression of tumorigenicity 2 |
| TEM | Transmission electron microscopy |
| TGF-β1 | Transforming growth factor beta 1 |
| TSG101 | Tumor susceptibility gene 101 |
| UBM | Urinary bladder matrix |
| VFLP | Vocal fold lamina propria |